Patents by Inventor John Feild

John Feild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bovine aggrecanase-1
    Publication number: 20020160492
    Abstract: Bovine aggrecanase-1 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds that either agonize or antagonize bovine aggrecanase-1. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: osteoarthritis, rheumatoid arthritis, joint injury, reactive and psoriatic arthritis and other diseases of bone.
    Type: Application
    Filed: July 25, 2001
    Publication date: October 31, 2002
    Inventors: Michael N. Cook, John Feild
  • Polynucleotide and polypeptide sequence of rabbit G-protein alpha 16
    Patent number: 6433156
    Abstract: Rabbit G alpha 16 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing rabbit G alpha 16 polypeptides and polynucleotides in screening of antagonists or agonists of cells co-expressing a G-protein coupled receptor and rabbit G alpha 16.
    Type: Grant
    Filed: December 22, 1998
    Date of Patent: August 13, 2002
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham plc
    Inventors: Robert S. Ames, John A. Feild, Tania Testa
  • Polynucleotide and polypeptide sequences encoding murine organic anion transporter 5 (mOATP5)
    Patent number: 6420544
    Abstract: Mouse OATP5 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds which either agonize or antagonize mouse OATP5. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: cancer, inflammation, cardiovascular disease, central nervous system disorders, auto-immune disease, and kidney and liver disease.
    Type: Grant
    Filed: May 17, 2000
    Date of Patent: July 16, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Harma Ellens, John Feild, Lin Yue
  • Polynucleotide and polypeptide sequence of rabbit G-protein alpha 16
    Publication number: 20020026042
    Abstract: Rabbit G alpha 16 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed.
    Type: Application
    Filed: September 12, 2001
    Publication date: February 28, 2002
    Inventors: Robert S. Ames, John A. Feild, Tania Testa
  • Human sodium dependent phosphate transporter (IPT-1)
    Patent number: 6350858
    Abstract: IPT-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IPT-1 polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, end stage renal disease, uremic bone disease, and cancer, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: April 19, 2000
    Date of Patent: February 26, 2002
    Assignee: SmithKline Beecham Corporation
    Inventor: John Feild
  • Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
    Patent number: 6319688
    Abstract: IPT-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IPT-1 polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, end stage renal disease, uremic bone disease, and cancer, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: November 20, 2001
    Assignee: SmithKline Beecham Corporation
    Inventor: John Feild
  • sbgFGF-19a
    Publication number: 20010012628
    Abstract: sbgFGF-19a polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing sbgFGF-19a polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: March 6, 2001
    Publication date: August 9, 2001
    Inventors: Pankaj Agarwal, Frank Barone, John A. Feild, Karen S. Kabnick, Michael S. McQueney
  • Polynucleotide and polypeptide sequences encoding rat mdr1b2 and screening methods thereof
    Patent number: 6169166
    Abstract: Rat mdr1b2 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds which either agonize or antagonize rat mdr1b2. Further disclosed is method for performing a selection screen, whereby compounds are discovered that neither agonize nor antagonize rat mdr1b2.
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: January 2, 2001
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham plc
    Inventors: Kimberly A. Brun, Richard J Chenery, Harma Ellens, John A Feild, Lin Yue
  • Polynucleotide and polypeptide sequences encoding rat mdr1b2 and screening methods thereof
    Patent number: 6025160
    Abstract: Rat mdr1b2 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds which either agonize or antagonize rat mdr1b2. Further disclosed is method for performing a selection screen, whereby compounds are discovered that neither agonize nor antagonize rat mdr1b2.
    Type: Grant
    Filed: July 22, 1998
    Date of Patent: February 15, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Kimberly A Brun, Richard J Chenery, Harma Ellens, John A Feild, Lin Yue
  • Rat cathepsin K polynucleotide and polypeptide sequence
    Patent number: 5948669
    Abstract: Rat cathepsin k polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing rat cathepsin k polypeptides and polynucleotides in the design of protocols for the treatment of osteoporosis, periodonatal disease, arthritis, cancer, tumor metastasis, and Paget's disease, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: February 26, 1997
    Date of Patent: September 7, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: John A. Feild, Kimberly Brun